WALTHAM, Mass., Oct. 02, 2025 (Korea Bizwire) – Moffitt Cancer Center and Evident, which recently acquired Pramana Inc., today announced a strategic partnership, leveraging the Pramana high-throughput scanning system to support digital adoption across Moffitt’s clinical and research programs. “Digital pathology is critical to advancing precision oncology,” said Karen Lu, MD, Executive Vice President and Physician-in-Chief at Moffitt Cancer Center. “Moffitt is committed to adopting technologies that support both clinical care and research innovation,” said William Westra, MD, Vice Chair of Pathology at Moffitt Cancer Center. These features provide a practical path for institutions adopting digital pathology at scale. “Evident is proud to work with Moffitt Cancer Center as it advances its digital pathology program,” said Wes Pringle, Evident CEO.